Alere Inc (ALR) 39.13 $ALR
Research Reports Initiation on Medical Laboratories & Research Stocks -- Quest Diagnostics, Bruker, Organovo, and Alere
PR Newswire - Wed Aug 31, 7:00AM CDT
Stock-Callers.com draws investors' attention to these Medical Laboratories and Research equities: Quest Diagnostics Inc. (NYSE: DGX), Bruker Corp. (NASDAQ: BRKR), Organovo Holdings Inc. (NASDAQ: ONVO), and Alere Inc. (NYSE: ALR). Industry growth is influenced by a number of trends, which include demographics, emerging economies, biotech advances in genetics, and pathogen evolution. Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
ONVO: 3.87 (+0.08), DGX: 83.04 (+0.68), BRKR: 22.38 (-0.06), ALR: 39.13 (+0.69)
Stock Market News for August 29, 2016
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:10AM CDT
Benchmarks ended a choppy trading session mostly in the red on Friday as investors continued to grapple with the timing of a rate hike
ABT: 42.09 (-0.21), YHOO: 43.28 (+0.35), NEE: 123.13 (+2.13), TERP: 13.24 (+0.39), DUK: 80.24 (+0.91), FB: 126.51 (+0.34), SNP: 73.37 (+2.03), VFC: 60.03 (-1.53), ALR: 39.13 (+0.69)
Abbott Labs Sued by Alere over Pending $5.8B Acquisition
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:38AM CDT
Abbott Labs (ABT) was sued by Alere (ALR) in the latter's attempt to force the former to complete the $5.8 billion takeover.
ABT: 42.09 (-0.21), ANIP: 59.86 (-1.56), ALR: 39.13 (+0.69)
Alere Falls 2.43% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Aug 26, 1:15PM CDT
Alere (AMEX:ALR) traded in a range yesterday that spanned from a low of $38.80 to a high of $42.12. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $40.17 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALR: 39.13 (+0.69)
Alere Issues Statement
PR Newswire - Fri Aug 26, 10:00AM CDT
Alere Inc. (NYSE: ALR) (the "Company"
, a global leader in rapid diagnostic tests, today issued the following statement in response to inquiries from its shareholders:
ALR: 39.13 (+0.69)
Alere (ALR) Receives FDA Approval for RSV Molecular Test
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:16AM CDT
Alere recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test.
QDEL: 21.58 (-0.16), LNTH: 9.40 (-0.10), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)
Alere (ALR) Reader Attains CE Mark, Submits Delayed 10K
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:08AM CDT
Alere Inc. (ALR) recently announced the receipt of In-Vitro Diagnostic (IVD) CE marking for its new Alere Reader.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)
Upgrade Alert for Alere (ALR)
Comtex SmarTrend(R) - Wed Aug 10, 3:11AM CDT
Alere (AMEX:ALR) was upgraded from Neutral to Buy at BTIG today. The stock closed yesterday at $39.27 on volume of 1.0 million shares, below average daily volume of 1.9 million. Alere, Inc. offers patient diagnosis, monitoring and health management services. The Company produces consumer and professional medical diagnostic products, and remotely monitors patients for pre-eclampsia, and patients who are prescribed Warfarin for atrial fibrillation.
ALR: 39.13 (+0.69)
Alere Achieves IVD CE Mark for its Alere(TM) Reader Lateral Flow Assay Analyzer
PR Newswire - Tue Aug 09, 6:00AM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced it has achieved In-Vitro Diagnostic (IVD) CE marking in Europe for its new Alere(TM) Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings. The Alere Reader will be initially available for use with the Alere BinaxNOW® Legionella and Streptococcus pneumoniae antigen cards, with other lateral flow applications and assays to follow.
ALR: 39.13 (+0.69)
SmarTrend Watching for Potential Pullback in Shares of Alere After 2.51% Gain
Comtex SmarTrend(R) - Mon Aug 08, 1:15PM CDT
Alere (AMEX:ALR) traded in a range yesterday that spanned from a low of $37.77 to a high of $40.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $37.52 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ALR: 39.13 (+0.69)
Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
PR Newswire - Mon Aug 08, 5:22AM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-K and reported its financial results for the fourth quarter and full year ended December 31, 2015.
ALR: 39.13 (+0.69)
Alere Opens New Diagnostics Manufacturing Facility in India
PR Newswire - Mon Aug 01, 3:15PM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced the opening of a state-of-the-art diagnostics manufacturing facility in Manesar, Haryana. The new factory will produce rapid tests for the detection of infectious diseases including Malaria, Dengue and HIV and export them across the Asia Pacific region, which is heavily impacted by these diseases.
ALR: 39.13 (+0.69)
Ford and Whole Foods skid, Alere and Facebook jump
AP - Thu Jul 28, 3:39PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:
BSX: 24.26 (-0.07), WFM: 30.78 (+0.22), F: 12.50 (+0.06), FB: 126.51 (+0.34), ALR: 39.13 (+0.69), GRPN: 5.36 (-0.03), MOH: 55.33 (+1.79)
Alere Comments on Pain Management Subpoena
PR Newswire - Wed Jul 27, 6:08PM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it received a U.S. Department of Justice subpoena addressed to Alere Toxicology Services, Inc. on July 1, 2016. The subpoena seeks records related to Medicare, Medicaid and Tricare billings dating back to 2010 for patient samples tested at the Company's Austin, Texas pain management laboratory. The Company is fully cooperating with the investigation.
ALR: 39.13 (+0.69)
Noteworthy Wednesday Option Activity: ALR, UNT, FORM
DividendChannel.com - Wed Jun 22, 2:28PM CDT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alere Inc. , where a total of 15,553 contracts have traded so far, representing approximately 1.6 million underlying shares.
ALR: 39.13 (+0.69)
GPM Reminds Investors of the June 20 Deadline in the Class Action Lawsuit Against Alere Inc.
BusinessWire - Mon Jun 20, 11:39AM CDT
Glancy Prongay & Murray LLP ("GPM" reminds investors of the June 20, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased Alere Inc. ("Alere" or the "Company" (NYSE: ALR) securities between May 9, 2013 and April 20, 2016, inclusive (the "Class Period" . Alere investors have until June 20, 2016 to file a lead plaintiff motion.
ALR: 39.13 (+0.69)
3-Day Deadline Alert: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Alere Inc. And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 17, 6:01PM CDT
IRVINE, CA / ACCESSWIRE / June 17, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company" (NYSE: ALR). Investors who purchased or otherwise acquired shares between May 9, 2013 and April 20, 2016, inclusive (the "Class Period" , are encouraged to contact the Firm prior to the June 20, 2016, lead plaintiff motion deadline.
ALR: 39.13 (+0.69)
DEADLINE ALERT, Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Alere, Inc. (ALR) and Lead Plaintiff Deadline: June 20, 2016
ACCESSWIRE - Fri Jun 17, 9:23AM CDT
NEW YORK, NY / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors of class action against Alere, Inc. ("Alere" or "the Company" (NYSE: ALR). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Alere, Inc. securities during the period between May 9, 2013 and April 20, 2016 inclusive (the "Class Period" .
ALR: 39.13 (+0.69)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Alere Inc. and a Lead Plaintiff Deadline of June 20, 2016 - ALR
GlobeNewswire - Tue Jun 14, 10:27AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Alere Inc. (NYSE:ALR) securities between May 9, 2013 and April 20, 2016.
ALR: 39.13 (+0.69)
JUNE 20 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. And Advises Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 10, 7:48PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 10, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company" (NYSE: ALR) concerning possible violations of federal securities laws between May 9, 2013 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the June 20, 2016, lead plaintiff motion deadline.
ALR: 39.13 (+0.69)
Research Reports Initiation on Medical Laboratories & Research Stocks -- Quest Diagnostics, Bruker, Organovo, and Alere
PR Newswire - Wed Aug 31, 7:00AM CDT
Stock-Callers.com draws investors' attention to these Medical Laboratories and Research equities: Quest Diagnostics Inc. (NYSE: DGX), Bruker Corp. (NASDAQ: BRKR), Organovo Holdings Inc. (NASDAQ: ONVO), and Alere Inc. (NYSE: ALR). Industry growth is influenced by a number of trends, which include demographics, emerging economies, biotech advances in genetics, and pathogen evolution. Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
ONVO: 3.87 (+0.08), DGX: 83.04 (+0.68), BRKR: 22.38 (-0.06), ALR: 39.13 (+0.69)
Stock Market News for August 29, 2016
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:10AM CDT
Benchmarks ended a choppy trading session mostly in the red on Friday as investors continued to grapple with the timing of a rate hike
ABT: 42.09 (-0.21), YHOO: 43.28 (+0.35), NEE: 123.13 (+2.13), TERP: 13.24 (+0.39), DUK: 80.24 (+0.91), FB: 126.51 (+0.34), SNP: 73.37 (+2.03), VFC: 60.03 (-1.53), ALR: 39.13 (+0.69)
Abbott Labs Sued by Alere over Pending $5.8B Acquisition
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:38AM CDT
Abbott Labs (ABT) was sued by Alere (ALR) in the latter's attempt to force the former to complete the $5.8 billion takeover.
ABT: 42.09 (-0.21), ANIP: 59.86 (-1.56), ALR: 39.13 (+0.69)
Alere Falls 2.43% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Aug 26, 1:15PM CDT
Alere (AMEX:ALR) traded in a range yesterday that spanned from a low of $38.80 to a high of $42.12. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $40.17 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALR: 39.13 (+0.69)
Alere Issues Statement
PR Newswire - Fri Aug 26, 10:00AM CDT
Alere Inc. (NYSE: ALR) (the "Company"
, a global leader in rapid diagnostic tests, today issued the following statement in response to inquiries from its shareholders: ALR: 39.13 (+0.69)
Alere (ALR) Receives FDA Approval for RSV Molecular Test
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:16AM CDT
Alere recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test.
QDEL: 21.58 (-0.16), LNTH: 9.40 (-0.10), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)
Alere (ALR) Reader Attains CE Mark, Submits Delayed 10K
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:08AM CDT
Alere Inc. (ALR) recently announced the receipt of In-Vitro Diagnostic (IVD) CE marking for its new Alere Reader.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)
Upgrade Alert for Alere (ALR)
Comtex SmarTrend(R) - Wed Aug 10, 3:11AM CDT
Alere (AMEX:ALR) was upgraded from Neutral to Buy at BTIG today. The stock closed yesterday at $39.27 on volume of 1.0 million shares, below average daily volume of 1.9 million. Alere, Inc. offers patient diagnosis, monitoring and health management services. The Company produces consumer and professional medical diagnostic products, and remotely monitors patients for pre-eclampsia, and patients who are prescribed Warfarin for atrial fibrillation.
ALR: 39.13 (+0.69)
Alere Achieves IVD CE Mark for its Alere(TM) Reader Lateral Flow Assay Analyzer
PR Newswire - Tue Aug 09, 6:00AM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced it has achieved In-Vitro Diagnostic (IVD) CE marking in Europe for its new Alere(TM) Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings. The Alere Reader will be initially available for use with the Alere BinaxNOW® Legionella and Streptococcus pneumoniae antigen cards, with other lateral flow applications and assays to follow.
ALR: 39.13 (+0.69)
SmarTrend Watching for Potential Pullback in Shares of Alere After 2.51% Gain
Comtex SmarTrend(R) - Mon Aug 08, 1:15PM CDT
Alere (AMEX:ALR) traded in a range yesterday that spanned from a low of $37.77 to a high of $40.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $37.52 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ALR: 39.13 (+0.69)
Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
PR Newswire - Mon Aug 08, 5:22AM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-K and reported its financial results for the fourth quarter and full year ended December 31, 2015.
ALR: 39.13 (+0.69)
Alere Opens New Diagnostics Manufacturing Facility in India
PR Newswire - Mon Aug 01, 3:15PM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced the opening of a state-of-the-art diagnostics manufacturing facility in Manesar, Haryana. The new factory will produce rapid tests for the detection of infectious diseases including Malaria, Dengue and HIV and export them across the Asia Pacific region, which is heavily impacted by these diseases.
ALR: 39.13 (+0.69)
Ford and Whole Foods skid, Alere and Facebook jump
AP - Thu Jul 28, 3:39PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:
BSX: 24.26 (-0.07), WFM: 30.78 (+0.22), F: 12.50 (+0.06), FB: 126.51 (+0.34), ALR: 39.13 (+0.69), GRPN: 5.36 (-0.03), MOH: 55.33 (+1.79)
Alere Comments on Pain Management Subpoena
PR Newswire - Wed Jul 27, 6:08PM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it received a U.S. Department of Justice subpoena addressed to Alere Toxicology Services, Inc. on July 1, 2016. The subpoena seeks records related to Medicare, Medicaid and Tricare billings dating back to 2010 for patient samples tested at the Company's Austin, Texas pain management laboratory. The Company is fully cooperating with the investigation.
ALR: 39.13 (+0.69)
Noteworthy Wednesday Option Activity: ALR, UNT, FORM
DividendChannel.com - Wed Jun 22, 2:28PM CDT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alere Inc. , where a total of 15,553 contracts have traded so far, representing approximately 1.6 million underlying shares.
ALR: 39.13 (+0.69)
GPM Reminds Investors of the June 20 Deadline in the Class Action Lawsuit Against Alere Inc.
BusinessWire - Mon Jun 20, 11:39AM CDT
Glancy Prongay & Murray LLP ("GPM"
reminds investors of the June 20, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased Alere Inc. ("Alere" or the "Company" (NYSE: ALR) securities between May 9, 2013 and April 20, 2016, inclusive (the "Class Period" . Alere investors have until June 20, 2016 to file a lead plaintiff motion. ALR: 39.13 (+0.69)
3-Day Deadline Alert: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Alere Inc. And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 17, 6:01PM CDT
IRVINE, CA / ACCESSWIRE / June 17, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company" (NYSE: ALR). Investors who purchased or otherwise acquired shares between May 9, 2013 and April 20, 2016, inclusive (the "Class Period" , are encouraged to contact the Firm prior to the June 20, 2016, lead plaintiff motion deadline. ALR: 39.13 (+0.69)
DEADLINE ALERT, Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Alere, Inc. (ALR) and Lead Plaintiff Deadline: June 20, 2016
ACCESSWIRE - Fri Jun 17, 9:23AM CDT
NEW YORK, NY / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors of class action against Alere, Inc. ("Alere" or "the Company"
(NYSE: ALR). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Alere, Inc. securities during the period between May 9, 2013 and April 20, 2016 inclusive (the "Class Period" . ALR: 39.13 (+0.69)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Alere Inc. and a Lead Plaintiff Deadline of June 20, 2016 - ALR
GlobeNewswire - Tue Jun 14, 10:27AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Alere Inc. (NYSE:ALR) securities between May 9, 2013 and April 20, 2016.
ALR: 39.13 (+0.69)
JUNE 20 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. And Advises Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 10, 7:48PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 10, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company"
(NYSE: ALR) concerning possible violations of federal securities laws between May 9, 2013 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the June 20, 2016, lead plaintiff motion deadline. ALR: 39.13 (+0.69)
